Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.740
+0.010 (0.58%)
At close: Sep 2, 2025, 4:00 PM
1.710
-0.030 (-1.72%)
After-hours: Sep 2, 2025, 5:48 PM EDT
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $281.79 million as of September 2, 2025. Its market cap has decreased by -84.24% in one year.
Market Cap
281.79M
Enterprise Value
84.16M
1-Year Change
-84.24%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $281.79M, a decrease of -89.09%. That is a compound annual growth rate of -67.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 280.17M | -83.64% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |